qc rp kits (mid kfsh d)

28
7/23/2019 Qc Rp Kits (Mid Kfsh d) http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 1/28 Medical Imaging Department Nuclear Medicine Section  Radiopharmaceutical QA Program NML-4 99m Tc-HDP  Procedure: System I: ITLC-SG / Acetone (HPLC grade) System II: ITLC-SG / Saline (0.! "aCl) #$ere% % Pertechnetate ( 99m TcO4 - ) & ! acti'ity at t$e sol'ent ront in System I. % Reduced-hydrolyzed Tc ( 99m TcO2 - ) & ! acti'ity remaining at t$e origin in System II % 99m Tc-HDP & (! acti'ity at t$e sol'ent ront in System II) - ! Pertec$netate ( m Tc* - ) or% & (! acti'ity remaining at t$e origin in System I) - ! +ed,ced- $ydrolyed Tc ( m Tc - ).  Results: % 99m Tc-HDP = 100 (% 99m TcO4 -  ! % 99m TcO2 - )

Upload: shibin-jayakrishnan

Post on 18-Feb-2018

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 1/28

Medical Imaging Department

Nuclear Medicine Section

  Radiopharmaceutical QA Program

NML-4

99m

Tc-HDP

 Procedure:

System I: ITLC-SG / Acetone (HPLC grade)

System II: ITLC-SG / Saline (0.! "aCl)

#$ere%

% Pertechnetate (99mTcO4-) & ! acti'ity at t$e sol'ent ront in System I.

% Reduced-hydrolyzed Tc (99mTcO2-) & ! acti'ity remaining at t$e origin in System

II

% 99mTc-HDP & (! acti'ity at t$e sol'ent ront in System II) - ! Pertec$netate

(mTc*-) or%

& (! acti'ity remaining at t$e origin in System I) - ! +ed,ced-

$ydrolyed Tc (mTc-).

 Results:

% 99mTc-HDP = 100 (%99mTcO4- ! %99mTcO2-)

Page 2: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 2/28

Medical Imaging Department

Nuclear Medicine Section

  Radiopharmaceutical QA Program

NML-4

99mTc-HDP

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH +adio$armacist

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Page 3: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 3/28

Medical Imaging Department

Nuclear Medicine Section

  Radiopharmaceutical QA Program

NM2

99mTc-D/*, Procedure:System I: ITLC-SG / et$yl 1t$yl 2eton (12)

System II: ITLC-SG / Saline (0.! "aCl)

#$ere%

% Pertechnetate (

99m

TcO4

-

) & ! acti'ity at t$e sol'ent ront in System I.% Reduced-hydrolyzed Tc (99mTcO2-) & ! acti'ity remaining at t$e origin in System

II

% 99mTc-D/*, & (! acti'ity at t$e sol'ent ront in System II) - ! Pertec$netate

(mTc*-) or%

& (! acti'ity remaining at t$e origin in System I) - ! +ed,ced-

$ydrolyed Tc (mTc-).

 Results:

% 99mTc-D/*, = 100 (%99mTcO4- ! %99mTcO2-)

Page 4: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 4/28

Medical Imaging Department

Nuclear Medicine Section

  Radiopharmaceutical QA Program

NM2

99m

Tc-D/*,

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Page 5: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 5/28

Medical Imaging Department

Nuclear Medicine Section

  Radiopharmaceutical QA Program

NM3

99m

Tc-DTP, Procedure:System I: ITLC-SG / et$yl 1t$yl 2eton(12)

System II: ITLC-SG / Saline (0.! "aCl)

#$ere%

% Pertechnetate (99mTcO4-) & ! acti'ity at t$e sol'ent ront in System I.

% Reduced-hydrolyzed Tc (99mTcO2-) & ! acti'ity remaining at t$e origin in System

II

% 99mTc-DTP, & (! acti'ity at t$e sol'ent ront in System II) - ! Pertec$netate

(mTc*-) or%

& (! acti'ity remaining at t$e origin in System I) - ! +ed,ced-

$ydrolyed Tc (mTc-).

 Results:

% 99mTc-DTP, = 100 (%99mTcO4- ! %99mTcO2-)

Page 6: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 6/28

Medical Imaging Department

Nuclear Medicine Section

  Radiopharmaceutical QA Program

NM3

  99mTc-DTP,

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Page 7: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 7/28

Medical Imaging Department

Nuclear Medicine Section

  Radiopharmaceutical QA Program

NM5

99mTc-H+D, der$at$e

 Procedure:Com3ination 3et4een t4o systems 4as ,sed or !+CP determination (UKRG, 2002) 

as a modiication o t$e standard met$od introd,ced 3y  Nunn et al (1983).

System I: #$atman 5 / 12 (6,tanone)

System II: ITLC-SG / 70! Acetonitril

 N.B. The spotted sample in system I should be dried with a hot air stream or in an

oven with a temperature less than 50 0C (in higher temperature the sample may be

damaged) before developing the strip in the solvent.

#$ere%

% Pertechnetate (99mTcO4-) & ! acti'ity at t$e sol'ent ront in System I (+   & 0.).

% Reduced-hydrolyzed Tc (99mTcO2-) & ! acti'ity remaining at t$e origin in System

II

% 99mTc-+D, & (! acti'ity at t$e sol'ent ront in System II) - ! Pertec$netate

(mTc* 

 Results:

% 99mTc-+D, = 100 (%99mTcO4- ! %99mTcO2-)

Page 8: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 8/28

Medical Imaging Department

Nuclear Medicine Section

  Radiopharmaceutical QA Program

NM5

99mTc-H+D, der$at$eDate " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Page 9: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 9/28

Medical Imaging Department

Nuclear Medicine Section

  Radiopharmaceutical QA Program

NM6

99mTc-H/P,O Procedure:

+CP 4ere o3tained t$ro,g$ a com3ination o t$ree c$romatogra$ic systems t$at

allo4 t$e ,ll 8,antitati'e assessment o t$e radioc$emical comosition o t$e

mi9t,re.

T$ese systems are:

ITLC-SG / saline ("aCl) system

ITLC-SG / et$yl-et$yl eton

#$atman no.; / 70! Acetonitril: 70! H

 T$en% ,sing t$ese t$ree c$romatogra$ic systems% t$e c$emical comosition o t$e

comle9 4as o3tained ,sing t$e ollo4ing relations$is:

% Pertechnetate (99mTcO4-) & ! acti'ity at t$e sol'ent ront in t$e ITLC-SG / "aCl

system.

% Reduced-hydrolyzed Tc (99mTcO2-) & ! acti'ity remaining at t$e origin in t$e

#$atman "o. ; / 70! Acetonitril: 70! H system.

% *econdary com#le' & ! acti'ity at +  f  & 0 < 0.5 in t$e ITLC/12 system < !

red,ced $ydrolyed Tc.% Pr$mary com#le' & ! acti'ity at +  f  & 0.5 < ; in t$e ITLC/12 system < !

 ertec$netate.

Page 10: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 10/28

Medical Imaging Department

Nuclear Medicine Section

  Radiopharmaceutical QA Program

NM6

99mTc-H/P,O

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Page 11: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 11/28

Medical Imaging Department

Nuclear Medicine Section

  Radiopharmaceutical QA Program

NM7

99mTc-/,,

 Procedure:Proer aer c$romatogra$y roced,re can 3e ,sed to searate mTc-AA rom ree

 ertec$netate. +T-* stris are ,sed as stationary $ase and ,cetone (HP

rade) as sol'ent.

#$ere%

% 99mTc-Pertechnetate & ! acti'ity at t$e sol'ent ront (+  & ;.0)

%99m

Tc-/,, and % Reduced-hydrolyzed Tc (99m

TcO2-

) = (! acti'ity remaining att$e origin (+  & 0.0).

Page 12: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 12/28

Medical Imaging Department

Nuclear Medicine Section

  Radiopharmaceutical QA Program

NM7

99mTc-/,,

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

Page 13: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 13/28

2

Medical Imaging Department

Nuclear Medicine Section

  Radiopharmaceutical QA ProgramNM8

99mTc-/a3

 Procedure:T4o c$romatogra$ic systems are ,sed to dierentiate 3et4een t$e t$ree ersisting secies

*ytem +" +T-* &thyl ,cetate-/&5 (3"2)

*ytem ++" +T-* 60% ,ceton$tr$l

#$ere%

% Pertechnetate (99mTcO4-) & ! acti'ity at t$e sol'ent ront in System I.

% Reduced-hydrolyzed Tc (99m

TcO2-

) & ! acti'ity remaining at t$e origin in System II% 99mTc-/,3 & (! acti'ity at t$e sol'ent ront in System II) - ! Pertec$netate ( mTc*-) or%

& (! acti'ity remaining at t$e origin in System I) - ! +ed,ced-$ydrolyed Tc (mTc-).

 Results:

% 99mTc-/,3 = 100 (%99mTcO4- ! %99mTcO2-)

Page 14: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 14/28

Medical Imaging Department

Nuclear Medicine Section

  Radiopharmaceutical QA Program

NM8

99mTc-/a3

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y*ytem %Pur$ty %+m#ur$ty

Page 15: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 15/28

  1

2

Medical Imaging Department

Nuclear Medicine Section

  Radiopharmaceutical QA Program

NM9

99mTc-/DP

 Procedure:System I: ITLC-SG / Acetone (HPLC grade)

System II: ITLC-SG / Saline (0.! "aCl)

#$ere%

% Pertechnetate (99mTcO4-) & ! acti'ity at t$e sol'ent ront in System I.

% Reduced-hydrolyzed Tc (99mTcO2-) & ! acti'ity remaining at t$e origin in System

II

% 99mTc-/DP & (! acti'ity at t$e sol'ent ront in System II) - ! Pertec$netate

(mTc*-) or%

& (! acti'ity remaining at t$e origin in System I) - ! +ed,ced-

$ydrolyed Tc (mTc-).

 Results:% 99mTc-/DP = 100 (%99mTcO4- ! %99mTcO2

-)

Page 16: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 16/28

Medical Imaging Department

Nuclear Medicine Section

  Radiopharmaceutical QA Program

NM9

99mTc-/DPDate " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Page 17: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 17/28

  Medical Imaging Department

Nuclear Medicine Section

Radiopharmaceutical QA Program

99mTc-/+.+

 Procedure:An acc,rate aer c$romatogra$y roced,re introd,ced 3y Patel et al7 (1996) can 3e

alied to searate mTc-I6I rom ot$er im,rities. 8hatman 3// #a#er stris

are ,sed as stationary $ase and 9979% ethyl acetate as sol'ent.

#$ere%

% 99mTc-/+.+ & ! acti'ity at t$e sol'ent ront (+  & 0.77-0.=7)

% Pertechnetate (99mTcO4-) ! % Reduced-hydrolyzed Tc (99mTcO2-) = (! acti'ity

remaining at t$e origin (+  & 0.0-0.;).

Page 18: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 18/28

Medical Imaging Department

Nuclear Medicine Section

Radiopharmaceutical QA Program

99m

Tc-/+.+Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

Samle ;

Samle

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

Samle ;

Samle

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

Samle ;

Samle

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

Samle ;

Samle

Page 19: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 19/28

Medical Imaging Department

Nuclear Medicine Section

Radiopharmaceutical QA Program

  99mTc-anocollo$d

 Procedure:S,ita3le aer c$romatogra$y roced,re can 3e ,sed to searate mTc-"anocolloid

rom ree ertec$netate. 8hatman &T-31stris are ,sed as stationary $ase and

079% al as sol'ent.

#$ere%

% 99mTc-Pertechnetate & ! acti'ity at t$e sol'ent ront (+  & ;.0)

%99m

Tc-anocollo$d and % Reduced-hydrolyzed Tc (99m

TcO2-

) = (! acti'ityremaining at t$e origin (+  & 0.0).

Page 20: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 20/28

Medical Imaging Department

Nuclear Medicine Section

Radiopharmaceutical QA Program

  99m

Tc-anocollo$d

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Page 21: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 21/28

Medical Imaging Department

Nuclear Medicine Section

Radiopharmaceutical QA Program

  99mTc-Pertechnetate Procedure:An acc,rate aer c$romatogra$y roced,re can 3e alied to searate mTc-

Pertec$netate rom ot$er im,rities. +T-* stris are ,sed as stationary $ase and

/ethyl &thyl 5eton(/&5) as sol'ent.

#$ere%

% 99mTc-Pertechnetate & ! acti'ity at t$e sol'ent ront (+  & 0.-;.0)

% Reduced-hydrolyzed Tc (99mTcO2-) and other $m#ur$t$e = (! acti'ity remaining

at t$e origin (+  & 0.0-0.;).

Page 22: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 22/28

  Medical Imaging Department

Nuclear Medicine Section

Radiopharmaceutical QA Program

  99m

Tc-PertechnetateDate " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Page 23: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 23/28

Medical Imaging Department

Nuclear Medicine Section

Radiopharmaceutical QA Program

  99mTc-Pyro#ho#hate

 Procedure:System I: ITLC-SG / Acetone (HPLC grade)

System II: ITLC-SG / Saline (0.! "aCl)

#$ere%

% Pertechnetate (99mTcO4-) & ! acti'ity at t$e sol'ent ront in System I.

% Reduced-hydrolyzed Tc (99mTcO2-) & ! acti'ity remaining at t$e origin in System

II

% 99mTc- P:P & (! acti'ity at t$e sol'ent ront in System II) - ! Pertec$netate

(mTc*-) or%

& (! acti'ity remaining at t$e origin in System I) - ! +ed,ced-

$ydrolyed Tc (mTc-).

 Results:

% 99mTc- P:P = 100 (%99mTcO4- ! %99mTcO2-)

Medical Imaging Department

Page 24: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 24/28

Nuclear Medicine Section

Radiopharmaceutical QA Program

  99mTc-Pyro#ho#hate

Date " Pre#arat$on t$me "$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Date " Pre#arat$on t$me "$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Page 25: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 25/28

Medical Imaging Department

Nuclear Medicine Section

Radiopharmaceutical QA Program

99mTc-*ul;ur ollo$d

 Procedure:Proer aer c$romatogra$y roced,re can 3e ,sed to searate mTc-SC rom ree

 ertec$netate. +T-* stris are ,sed as stationary $ase and ,cetone (HP

rade) as sol'ent.

#$ere%

% 99mTc-Pertechnetate & ! acti'ity at t$e sol'ent ront (+  & ;.0)

% 99mTc-* and % Reduced-hydrolyzed Tc (99mTcO2-) = (! acti'ity remaining at

t$e origin (+  & 0.0).

  Medical Imaging Department

Page 26: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 26/28

Nuclear Medicine Section

Radiopharmaceutical QA Program

99mTc-*ul;ur ollo$dDate " Pre#arat$on t$me "

$al lot no " &'#$re date: 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date: 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Date " Pre#arat$on t$me "

$al lot no " &'#$re date: 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

  1

2

Medical Imaging Department

Nuclear Medicine Section

Page 27: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 27/28

  Radiopharmaceutical QA Program

NML-1

99mTc-Tetro;om$n (/yo$e<)

 

>ate : Prearation time :

?ial lot no : 19ire date:

 

 Statonar! P"ase:

#$atman "o.;

 #o$le P"ase:

1t$yl Acetate .!

 Procedure:#$atman "0.;/ 1t$yl Acetate miniat,ried system can 3e ,sed s,ccess,lly to

searate t$e la3eled comle9 (mTc-Tetroosmin)% 4$ic$ migrates to t$e sol'ent ront

(+  & 0.*-0.@) rom t$e la3eling im,rities 4$ic$ remain at t$e origin (+  & 0.0- 0.;) .

Medical Imaging Department

Nuclear Medicine Section

Radiopharmaceutical QA Program

99m

Tc-Tetro;om$n (/yo$e<)

Page 28: Qc Rp Kits (Mid Kfsh d)

7/23/2019 Qc Rp Kits (Mid Kfsh d)

http://slidepdf.com/reader/full/qc-rp-kits-mid-kfsh-d 28/28

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

Samle ;

Samle

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

Samle ;

Samle

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

Samle ;

Samle

Date " Pre#arat$on t$me "

$al lot no " &'#$re date:

 

Reult %RP PH ,##roal .y

*ytem %Pur$ty %+m#ur$ty

Samle ;

Samle